Key Population: For patients with both type 2 diabetes and obesity, this medication offers a dual therapeutic benefit, making them the core target beneficiary group in clinical practice
Semaglutide has been associated with substantial weight loss in clinical trials, making it a potentially valuable option for individuals with both obesity and hypertension
Leaky Gut Syndrome (LGS) has been shown to lead to disease in all other parts of the body including but not limited to, the brain (causing in people amongst many other conditions, the following: Anxiety, Schizophrenia, Chronic fatigue syndrome, Alzheimers disease, Autism), the skin, the lungs, the kidneys, the pancreas, the liver and the heart (see In this article we will outline the functions of the gut , the physical changes (pathology) that occur to the gut, and what causes the pathology to develop the things that can be done to reverse the process to massively improve, (often cure), not just gut disease but many other disease processes in our pets
54 In an RCT for DJBL in patients with type 2 diabetes mellitus and obesity, 24% of the patients in the DJBL group achieved a 15% reduction in body weight compared to 4% in the control group at 12 months
wallichiana Steud
Learn more about common triggers of lower back pain like posture, exercise, and spondylosis